Insights & Analytics

Apple’s ResearchKit: 5 Rules For Pharma

To gauge the potential impact of ResearchKit on pharma, it’s important to recognize the specific challenges facing clinical trials and to imagine how, and if, ResearchKit will address these specific issues. With that in mind, here are five guidelines for pharma to focus on as the industry begins adapting to this powerful new medical research platform.

For a PDF version of the infographic, please click here.



The following two tabs change content below.
Ken Fabianovicz

Ken Fabianovicz

Ken Fabianovicz currently provides strategic digital marketing direction for Cadient Group. He focuses on precision-driven programs, strategies, and tactical thinking that serve clients in their efforts to build great pharmaceutical brands. Ken has worked in a wide range of therapeutic areas targeting consumers, healthcare professionals, and payers. Prior to joining Cadient Group, Ken was Group Account Supervisor at Dorland Global Health Communications for over 5 years. In addition, Ken spent several years as an Account Executive with both Integrated Communications Corporation and Dudnyk managing a number of US and Global accounts. Over the last 15 years, Ken has been involved with developing growth strategies and leading integrated marketing campaigns in multiple market segments, including DTP/DTC, professional, managed markets, Federal & State Government (Medicare / Medicaid), long-term care, and retail pharmacy. Ken graduated from Rowan University with a Bachelor of Arts degree in Advertising / Public Relations.

Most Popular

To Top